These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22777354)

  • 1. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
    Scribner KC; Behbod F; Porter WW
    Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2.
    Laffin B; Wellberg E; Kwak HI; Burghardt RC; Metz RP; Gustafson T; Schedin P; Porter WW
    Mol Cell Biol; 2008 Mar; 28(6):1936-46. PubMed ID: 18160708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bHLH/PAS transcription factor singleminded 2s promotes mammary gland lactogenic differentiation.
    Wellberg E; Metz RP; Parker C; Porter WW
    Development; 2010 Mar; 137(6):945-52. PubMed ID: 20150276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκB.
    Scribner KC; Wellberg EA; Metz RP; Porter WW
    Mol Endocrinol; 2011 Apr; 25(4):635-44. PubMed ID: 21292822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer.
    Wyatt GL; Crump LS; Young CM; Wessells VM; McQueen CM; Wall SW; Gustafson TL; Fan YY; Chapkin RS; Porter WW; Lyons TR
    Breast Cancer Res; 2019 Nov; 21(1):131. PubMed ID: 31783895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPbeta.
    Gustafson TL; Wellberg E; Laffin B; Schilling L; Metz RP; Zahnow CA; Porter WW
    Oncogene; 2009 Mar; 28(12):1561-8. PubMed ID: 19169276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
    Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
    J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.
    Shekhar MP; Kato I; Nangia-Makker P; Tait L
    Oncotarget; 2013 Feb; 4(2):231-41. PubMed ID: 23548208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition.
    Pearson SJ; Roy Sarkar T; McQueen CM; Elswood J; Schmitt EE; Wall SW; Scribner KC; Wyatt G; Barhoumi R; Behbod F; Rijnkels M; Porter WW
    Oncogene; 2019 Apr; 38(14):2611-2626. PubMed ID: 30531838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
    Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
    Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
    Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
    J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
    Lee S; Stewart S; Nagtegaal I; Luo J; Wu Y; Colditz G; Medina D; Allred DC
    Cancer Res; 2012 Sep; 72(17):4574-86. PubMed ID: 22751464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
    Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P
    J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
    Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
    Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
    Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
    J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
    Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
    Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
    Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
    Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.